Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Heart disease is the #1 killer of women — and medicine is finally catching up. Four major medical societies published a landmark female-specific framework for cardiovascular disease prevention and care, urging clinicians to track risk across key life stages like menstruation, pregnancy, and menopause. The framework also proposes a national network of Women's Cardiovascular Centers of Excellence to close persistent care gaps.
Heart disease kills more women each year than breast cancer, lung cancer, and chronic lung disease combined — yet only 41% of women recognize it as their greatest health threat. To close that gap, four major medical societies (the AHA, AAP, ACOG, and SMFM) jointly published three papers in Circulation introducing a Female Life Stage framework for cardiovascular disease prevention, detection, and management.
The framework urges clinicians to view cardiovascular risk through a female-specific lens, flagging biological milestones — menstrual cycle patterns, pregnancy complications like preeclampsia, and menopause — as key cardiovascular risk markers. It also calls for routine depression and anxiety screening starting at ages 12 and 13, respectively, and better care coordination across specialties from pediatrics through menopause.
To support implementation, the societies propose a national infrastructure of Comprehensive Centers of Excellence for Women's Cardiovascular Care — interdisciplinary hubs spanning clinical care, research, and community outreach.
By the Numbers:
Why it matters: Progress on women's cardiovascular health has stalled for two decades. This framework gives clinicians a shared playbook to identify risk earlier, reduce care fragmentation, and ultimately save lives — starting in childhood.
